Home LiteratureArticle Details
PMID: 6598803 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Inhibition of plasma membrane NADH dehydrogenase by adriamycin and related anthracycline antibiotics.

Journal of bioenergetics and biomembranes ·Vol. 16 ·No. 3 ·1984-06-00 ·Pages 209-21

Sun IL, Crane FL, Löw H, Grebing C

Abstract

Doxorubicin (adriamycin) is cytotoxic to cells, but the biochemical basis for this effect is unknown, although intercalation with DNA has been proposed This study suggests that the cytotoxicity of this drug may be due to inhibition of the plasma membrane redox system, which is involved in the control of cellular growth. Concentrations between 10(-6) - 10(-7) M adriamycin inhibit plasma membrane redox reactions greater than 50%. AD32, a form of adriamycin which does not intercalate with DNA, but is cytotoxic, also inhibits the plasma membrane redox system. Thus, the cytotoxic effects of adriamycin, which limit its use as a drug, may be based on the inhibition of a transplasma membrane dehydrogenase involved in a plasma membrane redox system.

MeSH Terms
Animals Antibiotics, Antineoplastic Cell Division/drug effects Cell Membrane/enzymology Cytochrome Reductases/antagonists & inhibitors Doxorubicin/pharmacology Liver/enzymology Mice NADH Dehydrogenase/antagonists & inhibitors NADH, NADPH Oxidoreductases/antagonists & inhibitors Naphthacenes/pharmacology Structure-Activity Relationship Swine
Chemicals
Antibiotics, Antineoplastic Naphthacenes Doxorubicin NADH, NADPH Oxidoreductases Cytochrome Reductases ferricyanide reductase NADH Dehydrogenase
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Sun I L
Crane F L
Löw H
Grebing C
References (50)
50 references, click to expand
  1. Effect of ethanol and lactate on the basal and glucagon-activated cyclic AMP formation in isolated hepatocytes.
    FEBS Lett. 1977 Mar 15;75(1):291-4 PMID: 192590
  2. Comparative ultrastructural studies of nucleoli of tumor cells treated with adriamycin and the newer anthracyclines, carminomycin and marcellomycin.
    Cancer Res. 1978 Feb;38(2):467-73 PMID: 202387
  3. DNA modification and cancer.
    Annu Rev Biochem. 1981;50:159-92 PMID: 6168236
  4. Intracellular pH Regulates Transitions Between Dormancy and Development of Brine Shrimp (Artemia salina) Embryos.
    Science. 1983 Jul 22;221(4608):366-8 PMID: 17798891
  5. NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals.
    Proc Natl Acad Sci U S A. 1979 Feb;76(2):954-7 PMID: 34156
  6. Mitochondrial NADH dehydrogenase-catalyzed oxygen radical production by adriamycin, and the relative inactivity of 5-iminodaunorubicin.
    FEBS Lett. 1983 Mar 7;153(1):227-30 PMID: 6298008
  7. Interference of daunomycin with metabolic events of the cell cycle in synchronized cultures of rat fibroblasts.
    Cancer Res. 1970 Apr;30(4):966-73 PMID: 5533993
  8. Adriamycin inactivates cytochrome c oxidase by exclusion of the enzyme from its cardiolipin essential environment.
    Biochem Biophys Res Commun. 1982 Jan 15;104(1):314-20 PMID: 6280691
  9. Ferricyanide can replace pyruvate to stimulate growth and attachment of serum restricted human melanoma cells.
    Biochem Biophys Res Commun. 1983 Apr 15;112(1):183-90 PMID: 6838605
  10. Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin.
    Biochem Biophys Res Commun. 1977 Jul 25;77(2):797-803 PMID: 20093
  11. Electron spin resonance study on the mode of generation of free radicals of daunomycin, adriamycin, and carboquone in NAD(P)H-microsome system.
    Gan. 1977 Oct;68(5):603-8 PMID: 22473
  12. Physical-chemical study of daunomycin-tubulin interactions.
    Arch Biochem Biophys. 1977 Jul;182(1):147-54 PMID: 883828
  13. Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation.
    Mol Pharmacol. 1977 Sep;13(5):901-10 PMID: 19695
  14. Energization of amino acid transport in energy-depleted Ehrlich cells and plasma membrane vesicles.
    Biochim Biophys Acta. 1980 Jun 20;599(1):175-90 PMID: 7397146
  15. Effects of reducing and oxidizing agents on the adenylate cyclase activity in adipocyte plasma membranes.
    FEBS Lett. 1976 May 15;65(1):96-8 PMID: 6332
  16. Inhibiting effect of the new cytotoxic antibiotic daunomycin on nucleic acids and mitotic activity of HeLa cells.
    J Cell Biol. 1965 Dec;27(3):545-50 PMID: 5885429
  17. Insulin control of a transplasma membrane NADH dehydrogenase in erythrocyte membranes.
    J Bioenerg Biomembr. 1982 Dec;14(5-6):425-33 PMID: 6761340
  18. New concepts on the interference of alkylating antitumor agents with the regulation of cell division.
    Adv Enzyme Regul. 1978;17:291-305 PMID: 757312
  19. Pulse radiolysis studies of antitumor quinones: radical lifetimes, reactivity with oxygen, and one-electron reduction potentials.
    Arch Biochem Biophys. 1981 Jun;209(1):119-26 PMID: 7283430
  20. Induction of intracellular ATP synthesis by extracellular ferricyanide in human red blood cells.
    J Membr Biol. 1969 Dec;1(1):214-24 PMID: 24174050
  21. Na+/H+ exchange and cytoplasmic pH in the action of growth factors in human fibroblasts.
    Nature. 1983 Aug 18-24;304(5927):645-8 PMID: 6410286
  22. Cell surface-mediated cytotoxicity of polymer-bound Adriamycin against drug-resistant hepatocytes.
    Cancer Res. 1983 Jun;43(6):2741-8 PMID: 6850589
  23. Correlations between cytotoxicity, biochemical effects, drug levels, and therapeutic effectiveness of daunomycin and adriamycin on Sarcoma 180 ascites in mice.
    Cancer Res. 1973 Nov;33(11):2954-8 PMID: 4748447
  24. Membrane-bound cytochrome b5 reductase (methemoglobin reductase) in human erythrocytes. Study in normal and methemoglobinemic subjects.
    J Clin Invest. 1981 Jan;67(1):149-55 PMID: 7451647
  25. Plasma membrane redox activities.
    Biochim Biophys Acta. 1982 Oct 20;694(2):203-23 PMID: 6753933
  26. Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivatives.
    Cancer Res. 1979 Sep;39(9):3661-72 PMID: 476691
  27. A simplified procedure for isolation of golgi apparatus from rat liver.
    Prep Biochem. 1972;2(1):61-9 PMID: 5019734
  28. Intracellular pH of mitogen-stimulated lymphocytes.
    Science. 1982 May 28;216(4549):1009-10 PMID: 6281887
  29. Nature of NADH: acceptor oxidoreductase in plasma membranes of mouse liver.
    Indian J Biochem Biophys. 1980 Jun;17(3):163-7 PMID: 7450801
  30. Immobilized adriamycin: a tool for separating cell surface from intracellular mechanisms.
    Fed Proc. 1983 Feb;42(2):284-7 PMID: 6822298
  31. Dehydrogenases of the plasma membrane.
    Subcell Biochem. 1979;6:345-99 PMID: 377585
  32. Evidence for a plasma membrane redox system on intact ascites tumor cells with different metastatic capacity.
    Biochim Biophys Acta. 1981 Jan 14;634(1):11-8 PMID: 7470494
  33. A differential interaction of daunomycin, adriamycin and their derivatives with human erythrocytes and phospholipid bilayers.
    Biochim Biophys Acta. 1978 Sep 22;512(2):254-69 PMID: 708725
  34. Hormone control of plasma membrane oxidation--reduction reactions. Effects of insulin.
    FEBS Lett. 1978 Jul 15;91(2):166-8 PMID: 680119
  35. The anticancer agent adriamycin can be actively cytotoxic without entering cells.
    Science. 1982 Jul 16;217(4556):248-50 PMID: 7089561
  36. Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes.
    Methods Enzymol. 1974;31:172-80 PMID: 4370662
  37. Adriamycin-a review.
    J Natl Cancer Inst. 1975 Dec;55(6):1265-74 PMID: 1107570
  38. NADH oxidoreductase of mouse liver plasma membranes.
    J Biol Chem. 1979 Apr 10;254(7):2491-8 PMID: 429296
  39. Hepatobiliary metabolism and excretion of adriamycin and N-trifluoroacetyladriamycin-14-valerate in the rat.
    Cancer Res. 1978 Feb;38(2):365-70 PMID: 620407
  40. Effects of adriamycin on surface properties of sarcoma 180 ascites cells.
    Biochem Pharmacol. 1976 May 15;25(10):1227-31 PMID: 945741
  41. An ascorbate-mediated transmembrane-reducing system of the human erythrocyte.
    J Clin Invest. 1979 Jan;63(1):53-8 PMID: 216708
  42. Synthesis of adriamycin-coupled polyglutaraldehyde microspheres and evaluation of their cytostatic activity.
    Proc Natl Acad Sci U S A. 1982 Mar;79(6):2026-30 PMID: 6804952
  43. Evidence for the extracellular reduction of ferricyanide by rat liver. A trans-plasma membrane redox system.
    Biochem J. 1981 Dec 15;200(3):565-72 PMID: 6282252
  44. Effects of anticancer agents on the respiration of isolated mitochondria and tumor cells.
    Eur J Cancer. 1974 Sep;10(9):567-74 PMID: 4461284
  45. Purification and properties of human erythrocyte membrane NADH-cytochrome b5 reductase.
    Arch Biochem Biophys. 1981 Aug;210(1):330-9 PMID: 7294831
  46. Inhibition of mitochondrial oxidative phosphorylation by adriamycin.
    Biochim Biophys Acta. 1983 Jan 13;722(1):43-50 PMID: 6218826
  47. Mechanism of iron uptake by peanut plants : I. Fe reduction, chelate splitting, and release of phenolics.
    Plant Physiol. 1983 Apr;71(4):949-54 PMID: 16662934
  48. The mitogenic activity of insulin: an intrinsic property of the molecule.
    Biochem Biophys Res Commun. 1980 Aug 14;95(3):1138-44 PMID: 6998473
  49. Transformed liver cells have modified transplasma membrane redox activity which is sensitive to adriamycin.
    Biochem Biophys Res Commun. 1983 Oct 14;116(1):210-6 PMID: 6639658
  50. Adriamycin affects plasma membrane redox functions.
    Biochem Biophys Res Commun. 1980 Apr 14;93(3):746-54 PMID: 7387672
Article Info
Journal
Journal of bioenergetics and biomembranes
Abbr.
J Bioenerg Biomembr
ISSN
0145-479X
Published
1984-06-00
Pages
209-21
Language
English
Region
United States
NLM ID
7701859
Subset
IM
Grants
NIGMS NIH HHS · GMK6-21839 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com